Antiviral agent 87
Antiviral agent 87 is a potent antiviral agent with low cytotoxicity in host cells. Antiviral agent 87 stabilizes prefusion HA conformation, blocks viral membrane fusion and host cell entry, and inhibits entry and replication of diverse influenza A virus subtypes. Antiviral agent 87 can be used for the research of influenza A virus infection.
For research use only. We do not sell to patients.
- CAS No.: 346715-10-4
- Formula: C15H15Cl2NO2S
- Molecular Weight:344.26
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | CC50 |
25 μM
Compound: 1
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 34260245] |
In Vitro
Antiviral agent 87 (compound 1) (0-125 nM; 2 h) inhibits replication of WSN-PB2-Nanoluc influenza virus in HCT116 cells in a dose-dependent manner, with an IC50 of 16.79 nM[1].
Antiviral agent 87 potently inhibits replication of A/WSN/33 (H1N1) influenza virus in A549 cells with an IC50 of 0.040 μM and exhibits no cytotoxicity at concentrations up to 25 μM, yielding a selectivity index >625[1].
Antiviral agent 87 (25 μM; 24-48 h) inhibits replication of diverse influenza A virus subtypes (H1N1, H5N1, H3N2) in A549 cells[1].
Antiviral agent 87 (8 h) inhibits entry of A/WSN/33 influenza virus into A549 cells[1].
Antiviral agent 87 (0.08-5 μM; 30 min) inhibits influenza virus-mediated membrane fusion and hemolysis of chicken erythrocytes[1].
Antiviral agent 87 (0.5-1 μM; 48 h) reduces levels of A/WSN/33 influenza virus M, HA, and NS mRNAs in A549 cells without affecting cellular RNA levels[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:A549 cells
-
Concentration:0.5; 1 μM
-
Incubation Time:48 h
-
Result:Decreased HA, NS1, M1, and M2 mRNA levels of A/WSN/33 (H1N1) influenza virus in A549 cells.
Chemical Information
-
CAS No. 346715-10-4
-
Molecular Weight 344.26
-
Formula C15H15Cl2NO2S
-
SMILES
O=S(C1=CC(Cl)=CC=C1Cl)(N(CC)C2=C(C)C=CC=C2)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Antiviral agent 87
- 346715-10-4
- Antiviral agent87
- Antiviral agent-87
- Influenza Virus
- A549 cells
- A/WSN/33 (H1N1) influenza virus
- chicken erythrocytes
- influenza A virus subtypes
- WSN-PB2-Nanoluc influenza virus
- H5N1
- H3N2
- host cells
- primary human bronchial epithelial cells
- influenza virus hemagglutinin protein
- Inhibitor
- inhibitor
- inhibit